Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson & Johnson Establishes Foundation To Support Terracotta Warriors

This article was originally published in PharmAsia News

Executive Summary

Johnson & Johnson and the Museum of Terra-cotta Warriors and Horses of Qin Shihuang have announced that genuine terracotta warriors will be displayed in the drug company's Olympics exhibition center during the Beijing Olympic Games. At the same time, both parties will continue to deepen their eight-year cooperation by jointly setting up a global foundation fund that will be used in four aspects: to strengthen R&D of the relics and terracotta site protection; enhance R&D personnel's education and training; communicate the knowledge of relic protection; and boost academic development by establishing awards, scholarships and qualification authentication. Johnson & Johnson officials say that establishing the fund is a reflection of its social responsibility toward China's priceless heritage. (Click here for more - Chinese Language)

You may also be interested in...



African Platform Eyes $750m Investment

Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.

Market Brief: Tissue-Engineered Wound Care Market Expected To Reach $1.9BN By 2024 Amid Rising Chronic Disease

The skin replacement market is led by three key players who have all been impacted by COVID-19, but the sector may see a quicker rebound than others as treatments cannot be deferred for a long time.

APACMed 2020: Healthineers Evolves Therapy Remit And Makes All Asia An Equal Priority

Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel